A Safety and Feasibility Study of Mitotane in Prostate Cancer
Condition(s):Prostate CancerLast Updated:December 17, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:December 17, 2015Completed
Condition(s):Adrenocortical CarcinomaLast Updated:March 8, 2023Completed
Condition(s):Adrenocortical CarcinomaLast Updated:May 8, 2017Unknown status
Condition(s):Adrenocortical CarcinomaLast Updated:October 30, 2018Unknown status
Condition(s):Recurrent Adrenocortical Carcinoma; Stage III Adrenocortical Carcinoma; Stage IV Adrenocortical CarcinomaLast Updated:April 29, 2014Terminated
Condition(s):Adrenocortical CarcinomaLast Updated:September 26, 2023Recruiting
Condition(s):ENSAT Stage I Adrenal Cortex Carcinoma; ENSAT Stage II Adrenal Cortex Carcinoma; ENSAT Stage III Adrenal Cortex CarcinomaLast Updated:December 20, 2023Recruiting
Condition(s):Adrenocortical CarcinomaLast Updated:September 21, 2023Recruiting
Condition(s):Adrenal Insufficiency; Adrenal CancerLast Updated:January 18, 2019Unknown status
Condition(s):Adrenocortical CarcinomaLast Updated:May 6, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.